Inhibikase Therapeutics, Inc. (IKT)
1.59
-0.04
(-2.45%)
USD |
NASDAQ |
Oct 23, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
Inhibikase Therapeutics Market Cap : 209.93M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 209.93M |
| October 22, 2026 | 215.21M |
| October 21, 2026 | 219.17M |
| October 20, 2026 | 225.78M |
| October 19, 2026 | 217.19M |
| October 16, 2026 | 217.85M |
| October 15, 2026 | 241.62M |
| October 14, 2026 | 237.66M |
| October 13, 2026 | 232.38M |
| October 12, 2026 | 243.60M |
| October 09, 2026 | 260.10M |
| October 08, 2026 | 252.18M |
| October 07, 2026 | 256.14M |
| October 06, 2026 | 261.42M |
| October 05, 2026 | 264.07M |
| October 02, 2026 | 264.07M |
| October 01, 2026 | 254.82M |
| September 30, 2026 | 271.33M |
| September 29, 2026 | 266.71M |
| September 28, 2026 | 270.67M |
| September 25, 2026 | 271.99M |
| September 24, 2026 | 277.27M |
| September 23, 2026 | 283.87M |
| September 22, 2026 | 305.00M |
| September 21, 2026 | 290.47M |
| Date | Value |
|---|---|
| September 18, 2026 | 303.68M |
| September 17, 2026 | 303.68M |
| September 16, 2026 | 305.00M |
| September 15, 2026 | 305.00M |
| September 14, 2026 | 315.56M |
| September 11, 2026 | 308.96M |
| September 10, 2026 | 307.64M |
| September 09, 2026 | 318.20M |
| September 08, 2026 | 320.84M |
| September 04, 2026 | 330.08M |
| September 03, 2026 | 332.72M |
| September 02, 2026 | 330.08M |
| September 01, 2026 | 314.24M |
| August 31, 2026 | 305.00M |
| August 28, 2026 | 318.20M |
| August 27, 2026 | 326.12M |
| August 26, 2026 | 328.76M |
| August 25, 2026 | 330.08M |
| August 24, 2026 | 330.08M |
| August 21, 2026 | 315.56M |
| August 20, 2026 | 310.28M |
| August 19, 2026 | 323.48M |
| August 18, 2026 | 316.88M |
| August 17, 2026 | 315.56M |
| August 14, 2026 | 318.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 1.369 |
| Price | 1.59 |
| Earnings Yield | -27.45% |